Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.20    -0.11 (-8.40%)
Bid:
1.10
Ask:
1.30
Spread: 0.20 (18.182%)
Market Cap: £10.27m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

FundamentalVR contract win

1 Dec 2020 07:00

RNS Number : 0088H
Tern PLC
01 December 2020
 

REACH

 

1 December 2020

 

Tern Plc

("Tern" or the "Company")

 

FundamentalVR contract win

 

Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to announce that its portfolio company, FVRVS Limited ("FundamentalVR"), has secured a three year contract worth a minimum of £0.9 million from a new client, which is a global medical device company (the "Client"), to accelerate the adoption, and subsequent safe and compliant use, of the Client's product.

 

The contract is for the creation of a virtual reality ("VR") platform, that will be embedded on a VR headset to accompany every installation of the Client's product, to teach and provide assistance to the end user. As well as covering the configuration of FundamentalVR's platform, the contract will also deliver recurring annual revenues over its three-year term from licences and support. The rollout of the VR simulation is intended to deliver the Client's ambitions to accelerate the safe and compliant use of their products by using FundamentalVR's unique HapticVRTM and multiuser @HomeVRTM technologies to provide users with the opportunity to rehearse, practice, and test themselves within a safe, controllable space that is as close to real-life as possible.

 

Commenting Al Sisto, CEO of Tern, said: "We are very pleased that FundamentalVR has secured this further significant contract win. This contract and the recently announced follow-on order from a global pharmaceutical client are, we believe, strong validations of FundamentalVR's technology. We look forward to the continuing progress of FundamentalVR and the securing of further contracts from their significant pipeline of opportunities."

 

Enquiries

 

Tern Plc

Al Sisto (CEO)

Sarah Payne (CFO)

via IFC Advisory

 

Allenby Capital Limited

(Nominated Adviser and Broker)

David Worlidge / Alex Brearley (Corporate Finance)

Guy McDougall (Equity Sales)

 

Tel: 0203 328 5656

 

IFC Advisory

(Financial PR and IR)

Tim Metcalfe

Graham Herring

Florence Chandler

 

Tel: 0203 934 6630

tern@investor-focus.co.uk

 

About FundamentalVR

 

FundamentalVR delivers VR haptic 'flight simulators' for surgery creating a safe, measurable and repeatable space to refine skills. FundamentalVR's goal is to transform the way surgeons prepare, practice, and refine their skills. It has built an immersive, surgical simulation application platform, Fundamental Surgery, to provide medical professionals with the opportunity to rehearse, practice, and test themselves within a safe, controllable space that is as close to real-life as possible.

 

Tern's shareholding in FundamentalVR is 26.9% and as at 30 June 2020 this holding had a book valuation of £3.0 million.

 

About Reach announcements

 

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFLFITLILIVII
Date   Source Headline
10th Mar 20227:00 amRNSWyld Networks Purchase Orders
2nd Mar 20227:00 amRNSParticipation in SVV UK Software Technology Fund
22nd Feb 20223:09 pmRNSDevice Authority Agreement with Avnet
11th Feb 20227:00 amRNSPortfolio Update
1st Feb 20227:00 amRNSTalking Medicines Fund Raise
11th Jan 20221:45 pmRNSWyld Networks Connectivity Partnership
31st Dec 202112:30 pmRNSTotal Voting Rights
29th Dec 20214:41 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
23rd Dec 202112:30 pmRNSChange in Wyld Networks Shareholding
20th Dec 20217:00 amRNSInVMA Fund Raise and Update
15th Dec 20213:04 pmRNSExercise of Options
13th Dec 20214:41 pmRNSSecond Price Monitoring Extn
13th Dec 20214:36 pmRNSPrice Monitoring Extension
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension
8th Dec 20219:00 amRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
3rd Dec 20219:00 amRNSPrice Monitoring Extension
2nd Dec 20214:41 pmRNSSecond Price Monitoring Extn
2nd Dec 20214:35 pmRNSPrice Monitoring Extension
2nd Dec 20212:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
2nd Dec 202110:01 amRNSDevice Authority Strategic Investment & Funding
1st Dec 20217:00 amRNSDevice Authority convertible loan notes
26th Oct 20217:00 amRNSPortfolio Update
20th Sep 20217:30 amRNSWyld purchase order from Bayer Crop Science
16th Sep 20217:00 amRNSInvestor webinar recording
14th Sep 20217:00 amRNSInterim Results
3rd Sep 20214:40 pmRNSSecond Price Monitoring Extn
3rd Sep 20214:35 pmRNSPrice Monitoring Extension
3rd Sep 20212:05 pmRNSSecond Price Monitoring Extn
3rd Sep 20212:00 pmRNSPrice Monitoring Extension
3rd Sep 202111:05 amRNSSecond Price Monitoring Extn
3rd Sep 202111:00 amRNSPrice Monitoring Extension
25th Aug 20217:00 amRNSWyld Networks Third Party Funding
17th Aug 20217:00 amRNSInvestment in FundamentalVR and Portfolio Update
4th Aug 20214:41 pmRNSSecond Price Monitoring Extn
4th Aug 20214:35 pmRNSPrice Monitoring Extension
4th Aug 20212:06 pmRNSSecond Price Monitoring Extn
4th Aug 20212:00 pmRNSPrice Monitoring Extension
30th Jul 20215:18 pmRNSTotal Voting Rights
14th Jul 20217:00 amRNSResult of Fundraise
13th Jul 20215:07 pmRNSRetail Offer
13th Jul 20215:05 pmRNSEquity Fundraise of up to £4 million
2nd Jul 20218:05 amRNSWyld Networks - Trading on NASDAQ First North
28th Jun 202110:00 amRNSWyld Networks IPO Update
25th Jun 20214:40 pmRNSSecond Price Monitoring Extn
25th Jun 20214:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.